| Pharmaceutical active ingredients: |
| Ergoloid Mesylates |
| Available forms, composition and doses of Dorehydrin Retard: |
| Capsules, Retard; Oral; Ergoloid Mesylates 2.5 mgCapsules, Retard; Oral; Ergoloid Mesylates 4.5 mg |
| Dorehydrin Retard medical category: |
| Human:Sympatholytic (adrenergic blocking) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C04AE01 - Ergoloid Mesylates |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanova Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Dore Immun | Echinacea | Dr. Rentschler Arzneimittel |
| Dorecotuss Retard | Dextromethorphan Hydrobromide; Ephedrine Hydrochloride | Dr. Rentschler Arzneimittel |
| Doregrippin | Acetaminophen; Phenylephrine Hydrochloride | Dr. Rentschler Arzneimittel; Medice Arzneimittel Putter |
| Doregrippin S | Diphenylpyraline Hydrochloride; Ethenzamide | Dr. Rentschler Arzneimittel |
| Dorehydrin | Ergoloid Mesylates | Sanova Pharma |
| Do-Re-Me | Dosulepin | Intas Pharmaceuticals |
| Dorenasin | Xylometazoline Hydrochloride | Dr. Rentschler Arzneimittel |
| Dorend | Acetaminophen; Phenylbutazone | Teuto-Brasileiro Laboratorio |
| Dorent | Donepezil Hydrochloride | Torrent Pharmaceuticals |
| Doreperol N | Hexetidine | Dr. Rentschler Arzneimittel |